DNA methylation in health and disease

Nature Reviews Genetics

Volumn 1, Issue 1, 2000, Pages 11-19

  Robertson, Keith D ^a   Wolffe, Alan P ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SANGAMO BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLATION; GENETIC DISORDER; GENETICS; GENOME; HUMAN; REVIEW;

DNA METHYLATION; GENETIC DISEASES, INBORN; GENOME; HUMANS;

EID: 0034305821     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35049533     Document Type: Review

References (101)

1. Lei, H. et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 3195-3205 (1996).
2. Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
3. Okano, M., Bell, D. W., Haber, D. A. & Li, W. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999). References 2 and 3 describe the effects of loss of Dnmt1, Dnmt3a and Dnmt3b on mouse development.
4. Bird, A. P. Gene number, noise reduction and biological complexity. Trends Genet. 11, 94-99 (1995).
5. Steinbach, O. C., Wolffe, A. P. & Rupp, R. A. Somatic linker histories cause loss of mesodermal competence in Xenopus. Nature 389, 395-399 (1997).
6. Mannervik, M., Nibu, Y., Zhang, H. & Levine, M. Transcriptional coregulators in development. Science 284, 606-609 (1999).
7. Baylin, S. B., Herman, J. G., Herman, J. R., Vertino, P. M. & Issa, J.-P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196 (1998).
8. Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nature Genet. 21, 163-166 (1999). References 7 and 8 are good reviews on the roles of DNA methylation in cancer.
9. Jaenisch, R. DNA methylation and imprinting: why bother? Trends Genet 13, 323-329 (1997).
10. Jirtle, J. L., Sander, M. & Barrett, J. C. Genomic imprinting and environmental disease susceptibility. Environ. Health Perspect. 108, 271-278 (2000).
11. Tyko, B. & Ashkenas, J. Epigenetics and its role in disease. J. Clin. Invest. 105, 245-246 (2000).
12. Post, W. S. et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985-991 (1999).
13. Cooper, D. N. & Krawczak, M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum. Genet. 83, 181-188 (1989).
14. Bird, A., Taggart, M., Frommer, M., Miller, O. J. & Macleod, D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 10, 91-99 (1985).
15. Antequera, F. & Bird, A. Number of CpG islands and genes in human and mouse. Proc. Natl Acad. Sci. USA 90, 11995-11999 (1993).
16. Tazi, J. & Bird, A. Alternative chromatin structure at CpG islands. Cell 60, 909-920 (1990).
17. Jiricny, J. in Cancer Surveys: Genetic Instability in Cancer Vol. 28 47-68 (Imperial Cancer Research Fund, 1996).
18. Cooper, D. N. & Youssoufian, H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78, 151-155 (1988).
19. Rideout, W. M. I., Coetzee, G. A., Olumi, A. F. & Jones, P. A. 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249, 1288-1290 (1990).
20. Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
21. Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J. Mol. Biol. 203, 971-983 (1988).
22. Pradhan, S., Bacolla, A., Wells, R. D. & Roberts, R. J. Recombinant human DNA (cytosine-5) methyltransferase I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 274, 33002-33010 (1999).
23. Pradhan, S. et al. Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase. Nucleic Acids Res. 25, 4666-4673 (1997).
24. Robertson, K. D. et al. The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27, 2291-2298 (1999).
25. Leonhardt, H., Page, A. W. Weier, H. & Bestor, T. H. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71, 865-873 (1992).
26. Wα′1. Science 277, 1996-2000 (1997).
27. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
28. Beard, C., Li, E. & Jaenisch, R. Loss of methylation activates Xist in somatic but not in embryonic cells. Genes Dev. 9, 2325-2334 (1995).
29. Hung, M.-S. et al. Drosophila proteins related to vertebrate DNA (5-cytosine) methyltransferases. Proc. Natl Acad. Sci. USA 96, 11940-11945 (1999).
30. Tweedie, S. et al. Vestiges of DNA methylation system in Drosophila melanogaster. Nature Genet. 23, 389-390 (1999).
31. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
32. Cao, X. et al. Conserved plant genes with similarity to mammalian de novo DNA methyltransferases. Proc. Natl Acad. Sci. USA 97, 4979-4984 (2000).
33. Lyko, L. et al. Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. Nature Genet. 23, 363-366 (1999).
34. Vertino, P. M., Yen, R.-W. C., Gao, J. & Baylin, S. B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5)-methyltransferase. Mol. Cell. Biol. 16, 4555-4565 (1996). This paper uniquely describes the use of somatic cell knockout technology to delete the DNMT1 gene in a cancer cell line.
35. Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003-1007 (2000).
36. Robertson, K. D. et al. DNMT1 forms a complex with Rb, E2F1, and HDAC1 and represses transcription from E2F-responsive promoters. Nature Genet. 25, 338-342 (2000).
37. Roundtree, M. R., Bachman, K. E. & Baylin, S. B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication loci. Nature Genet. 25, 269-277 (2000).
38. Yoder, J. A., Walsh, C. P. & Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13, 335-340 (1997).
39. Colot, V. & Rossignol, J.-L. Eukaryotic DNA methylation as an evolutionary device. BioEssays 21, 402-411 (1999).
40. Montagna, M. et al. Identificatton of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 18, 4160-4165 (1999).
41. Kazazian, J. H. H. & Moran, J. V. The impact of L1 retrotransposons on the human genome. Nature Genet. 19, 19-24 (1998).
42. Kochanek, S., Renz, D. & Doerfler, W. Transcriptional silencing of human Alu sequences and inhibition of protein binding in the B box regulatory elements by 5′-CG-3′ methylation. FEBS Lett. 360, 115-120 (1995).
43. Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93 (1998).
44. Walsh, C. P., Chaillet, J. R. & Bestor, T. H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nature Genet. 20, 116-117 (1998).
45. Waugh-O'Neill, R. J., O'Neill, M. J. & Marshall-Graves, J. A. Undermethylation associated with retroelement activation and chromosome remodeling in an interspecific mammalian hybrid. Nature 393, 68-72 (1988).
46. Flori, A. R., Lower, R., Schmitz-Drager, B. J. & Schulz, W. A. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br. J. Cancer 80, 1312-1321 (1999).
47. Grassi, M., Girault, J. M., Wang, W. P., Thiery, J. P. & Jouanneau, J. Metastatic rat carcinoma cells express a new retrotransposon. Gene 233, 59-66 (1999).
48. Puget, N. et al. A 1-kb Alu-mediated germ-line deletion removing BFCA1 exon 17. Cancer Res. 57, 828-831 (1997).
49. Rouyer, F., Simmler, M. C., Page, D. & Weissenbach, J. A sex chromosome rearrangement in a human XX male caused by Alu-Alu recombination. Cell 51, 417-425 (1987).
50. Small, K., Iber, J. & Warren, S. T. Emerin deletion reveals a common X chromosome inversion mediated by inverted repeats. Nature Genet. 16, 96-99 (1997).
51. Maloisel, L. & Rossignol, J.-L. Suppression of crossing-over by DNA methylation in Ascobolus. Genes Dev. 12, 1381-1389 (1998).
52. Hsieh, C.-L. & Lieber, M. R. CpG methylated minichromosomes become inaccessible for V(D)J recombination after undergoing replication. EMBO J. 11, 3115-325 (1992).
53. Paldi, A., Gyapay, G. & Jami, J. Imprinted chromosomal regions of the human genome display sex-specific meiotic recombination frequencies. Curr. Biol. 5, 1030-1035 (1995).
54. Miniou, P. et al. Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum. Mol. Genet. 3, 2093-2102 (1994).
55. Ji, W. et al. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 379, 33-41 (1997).
56. Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187-191 (1998).
57. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 invloves a histone deacetylase complex. Nature 393, 386-389 (1998). References 56 and 57 were the first reports to link DNA methylation to methyl-CpG binding proteins and chromatin-remodelling factors, such as histone deacetylase.
58. Tate, P. H. & Bird, A. P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226-231 (1993).
59. Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992).
60. Wakefield, R. I. D. et al. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 291, 1055-1065 (1999).
61. Nan, X., Campoy, F. J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481 (1997). This paper was the first to report that Rett syndrome was associated with mutations in the MeCP2 gene.
62. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein. Nature Genet. 23, 185-188 (1999).
63. Kaludov, N. & Wolffe, A. P. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res. 28, 1921-1928 (2000).
64. Nan, X., Tate, P., Li, E. & Bird, A. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 10, 414-421 (1996).
65. Chandler, S. P., Guschin, D., Landsberger, N. & Wolffe, A. P. The methyl CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38, 7008-7018 (1999).
66. Buschhausen, G., Wittig, B., Graessmann, M. & Graessmann, A. Chromatin structure is required to block transcription from the methylated herpes simplex virus thymidine kinase gene. Proc. Natl Acad. Sci. USA 84, 1177-1181 (1986).
67. Kass, S. U., Landsberger, N. & Wolffe, A. P. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7, 157-165 (1997).
68. Wade, P. A. et al. The Mi-2 complex couptes DNA methylation to chromatin remodelling and histone deacetylation. Nature Genet. 23, 62-66 (1999).
69. Ng, H.-H. et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nature Genet. 23, 58-61 (1999).
70. Tse, C., Sera, T., Wolffe, A. P. & Hansen, J. C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell. Biol. 18, 4629-4638 (1998).
71. Ng, H.-H., Jeppesen, P. & Bird, A. Active repression of methylated genes by the chromosomal protein MBD1. Mol. Cell. Biol. 20, 1394-1406 (2000).
72. Fujita, N. et al. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding proton MBD1 isoforms. Mol. Cell. Biol. 19, 6415-6426 (1999).
73. Fuks, F., Bergers, W. A., Brehm, A., Hughes-Davies, L. & Kouzarides, T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet. 24, 88-91 (2000).
74. Gibbons, R. J. et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the patterns of DNA methylation. Nature Genet. 24, 368-371 (2000).
75. Jeddeloh, J. A., Stokes, T. L. & Richards, E. J. Maintenance of genomic methylation requires a SWI2/SNF2-like protein. Nature Genet. 22, 94-97 (1999).
76. Goto, K. et al. Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice. Differentiation 56, 39-44 (1993).
77. Endres, M. et al. DNA methyltransferase contributes to delayed ischemic brain injury. J. Neurosci. 20, 3175-3181 (2000).
78. Smeets, D. F. C. M. et al. ICF syndrome: a new case and review of the literature. Hum. Genet. 94, 240-246 (1994).
79. Franceschini, P. et al. Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anamolies syndrome. Eur. J. Pediatr. 154, 840-846 (1995).
80. Tagarro, I., Fernandez-Peralta, A. M. & Gonzales-Aguilera, J. J. Chromosomal localization of human satellites 2 and 3 by FISH method using oligonucleotides as probes. Hum. Genet. 93, 383-388 (1994).
81. Jeanpierre, M. et al. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum. Mol. Genet. 2, 731-735 (1993).
82. Kondo, T. et al. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 9, 597-604 (2000).
83. Xu, G.-L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187-191 (1999).
84. Hansen, R. S. et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA 96, 14412-14417 (1999).
85. Xie, S. et al. Cloning, expression and chromosome locations of the human DNMT3 gene famay. Gene 236, 87-95 (1999). References 83-85 were the first to report that ICF syndrome is associated with mutations in the DNMT3B gene.
86. Wijmenga, C. et al. Localization of the ICF syndrome to chromosome 20 by heterozygosity mapping. Am. J. Hum. Genet. 63, 803-809 (1998).
87. Hagberg, B., Aicardi, J., Dias, K. & Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14, 471-479 (1983).
88. Wan, M. et al. Rett syndrome and beyond: recurrent spontaneous familial MECP2 mutations at CpG hotspots. Am. J. Hum. Genet. 65, 1520-1529 (2000).
89. Ballestar, E., Yusufzai, T. M. & Wolffe, A. P. The effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39, 7100-7106 (2000).
90. Tate, P., Skarnes, W. & Bird, A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nature Genet. 12, 205-208 (1996).
91. Willard, H. F. & Hendrich, B. D. Breaking the silence in Rett syndrome. Nature Genet. 23, 127-128 (1999).
92. Bird, A. & Tweedie, S. Transcriptional noise and the evolution of gene number. Phil. Trans. R. Soc. Lond. 349, 249-253 (1995).
93. Warren, S. T. & Nelson, D. L. Trinucleotide repeat expansions in neurological disease. Curr. Opin. Neurobiol. 3, 752-759 (1993).
94. Kremer, E. J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714 (1991).
95. Oberle, I. et al. Instability of a 550-base pair segment and abnormal methylation in Fragile X Syndrome. Science 252, 1097-1102 (1991). References 94 and 95 were among the first to show that lack of expression of the FMR1 gene was associated with abnormal expansion and methylation of a trinucleotide repeat.
96. Coffee, B., Zhang, F., Warren, S. T. & Reines, D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nature Genet. 22, 98-101 (1999).
97. Fu, Y. H. et al. Variation of the CGG repeat at the Fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67, 1047-1058 (1991).
98. Smith, S. S., Laayoun, A., Lingeman, R. G., Baker, D. J. & Riley, J. Hypermethylation of telomere-like foldbacks at codon 12 of the human c-Ha ras gene and the trinucleotide repeat of the FMR-1 gene of fragile X. J. Mol. Biol. 243, 143-151 (1994).
99. Feng, Y. et al. FMRP associates with polyribosomes as an mRNP, and the 1304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109-118 (1997).
100. Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 10, 6538-6547 (1998).
101. Hornstra, I. K., Nelson, D. L., Warren, S. T. & Yang, T. P. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum. Mol. Genet. 2, 1659-1665 (1993).